Cronos Group Inc. Files 2024 DEF 14A
Ticker: CRON · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1656472
| Field | Detail |
|---|---|
| Company | Cronos Group Inc. (CRON) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: CRON
TL;DR
Cronos Group (CRON) filed its 2024 proxy statement, detailing exec pay and equity awards. Look for details on Gorenstein and Schmidt.
AI Summary
Cronos Group Inc. filed its DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key financial periods reported include the fiscal years 2024, 2023, and 2022, with specific data points related to equity awards granted to both PEO (Principal Executive Officer) and Non-PEO NEOs (Non-Principal Executive Officer Named Executive Officers).
Why It Matters
This filing provides crucial insights into how Cronos Group Inc. compensates its top executives, which can influence investor decisions and perceptions of the company's financial health and management strategy.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal significant information about executive compensation, potential conflicts of interest, and shareholder proposals that could impact the company's future performance.
Key Numbers
- 2024 — Fiscal Year End (Primary period covered by the filing)
- 2023 — Prior Fiscal Year (Comparative financial data)
- 2022 — Prior Fiscal Year (Comparative financial data)
Key Players & Entities
- Cronos Group Inc. (company) — Filer of the DEF 14A
- 2024-12-31 (date) — Fiscal year end
- 20250425 (date) — Filing date
- Gorenstein (person) — Executive mentioned in relation to equity awards
- Schmidt (person) — Executive mentioned in relation to equity awards
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
Who are the key executives mentioned in relation to equity awards for Cronos Group Inc. in this filing?
The filing mentions 'GorensteinMember' and 'SchmidtMember' in the context of equity awards for the fiscal years 2024, 2023, and 2022.
What is the fiscal year end for Cronos Group Inc. as reported in this DEF 14A?
The Conformed Period of Report is 20241231, indicating the fiscal year ends on December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
The filing was submitted on April 25, 2025, as indicated by the 'FILED AS OF DATE: 20250425'.
What type of products does Cronos Group Inc. operate within, according to its SIC code?
Cronos Group Inc. is classified under MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 by Gorenstein regarding Cronos Group Inc. (CRON).